MyProstateScore 2.0 (MPS2) offers physicians and patients the most comprehensive and flexible prostate cancer risk assessment tool. I am a Provider I am a Patient MYPROSTATESCORE 2.0 Clear Results. Confident Decision. MPS2 is a urine test designed to predict the presence of clinically significant...
Risk of high-grade cancer on a prostate biopsy nomogramis used to estimate the likelihood of having high-grade prostate cancer in people who have been considered eligible for prostate biopsy by a urologist. This tool does not apply to those who have already been diagnosed with prostate cancer....
Prostate cancer risk assessmentPCPT risk calculatorAge and race-specific reference rangesWhile the current value of prostate cancer screening in reducing mortality is debatable, there is no doubt that screening has created overdetection of clinically insignificant cancers. An......
Prostate cancer risk assessment tools in an unscreened population. World J Urol. 2015;33(6):827-832.PubMedGoogle ScholarCrossref 92. Ankerst DP, Hoefler J, Bock S, et al. Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer. ...
Prostate cancer risk assessment model: a scoring model based on the Swedish Family-Cancer Database H, Hemminki K, Brandt A, Sundquist J, Fallah M: Prostate cancer risk assessment model: a scoring model based on the Swedish Family-Cancer Database... H Roudgari,K Hemminki,A Brandt,... ...
Objective To perform a systematic review of data guiding the assessment of elderly prostate cancer patients that addresses the risk from cancer and treatment, and to discuss a patient-centered approach to incorporating these factors into decision making. Evidence acquisition Evidence was gathered via a...
Medications and other factors can skew a PSA test and impact your prostate cancer risk assessment. Here's what to avoid before a PSA test.
To evaluate the validity of the cancer of the prostate risk assessment (CAPRA) score, a newly developed nomogram for preoperative prediction of recurrence after radical prostatectomy, in a single institution in Korea. We retrospectively studied 115 men who had undergone radical prostatectomy as the fi...
Traditional Prostate Cancer Risk Assessment Scales Do Not Predict Outcomes from Brain Metastases: A Population-Based Predictive Nomogram Brain metastases are an uncommon yet life-limiting manifestation of prostate cancer. However, there is limited insight into the natural progression, therap... EA Marvin...
"It was previously thought that PSA levels were just naturally higher in African-American men, suggesting a need to possibly adjust the threshold upward before recommending a biopsy," said Veda Giri, M.D., director of the Prostate Cancer Risk Assessment Program at Fox Chase Cancer Center. ...